The purpose of this study is to evaluate the levels of morphine in a patients blood when
morphine is given into the epidural space in the form of DepoDur® either alone or following
a dose of lidocaine also given in the epidural space. Specifically, we are looking at
pregnant women undergoing cesarean delivery who will be receiving these medications. A
secondary objective is to evaluate the how well DepoDur® works for pain control, as well as
its safety, when it is given either alone or following a dose of epidural lidocaine.
Stanford is currently not accepting patients for this trial.
For more information, please contact Brendan Carvalho, (650) 861 - 8607.
View full details